Latest Headlines

31. Tezalon Biotech & Strikebox Partner To Advance Scalable Bioprocess Solutions 8/28/2025

    Tezalon Biotech, a leader in automation-ready bioprocess systems and single use mixers, is proud to announce a strategic partnership with Strikebox, a specialized bioprocess equipment design and manufacturing firm based in Mullingar, Ireland. This collaboration brings together deep bioprocess engineering expertise and world-class precision fabrication to deliver scalable, customer-centric solutions for the global life sciences industry.

32. Asimov Announces Cell Line Development Partnership With Ottimo Pharma To Accelerate Cancer Immunotherapy's Path To Clinic 8/27/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a cell line development partnership with Ottimo Pharma, a biopharmaceutical company developing first-in-class, one-of-a-kind PD1/VEGFR2 dual pathway antibodies to extend the lives of people living with cancer.

33. Biorasi And Ryght AI Partner To Revolutionize Clinical Trial Feasibility With Real-Time AI Insights 8/26/2025

    In a move set to redefine how biotech and biopharma sponsors plan and launch clinical trials, Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies, has partnered with Ryght AI & to bring advanced, AI-driven feasibility capabilities to biotech and biopharma sponsors.

34. CDMO Made Scientific Opens New Cell Therapy Manufacturing Facility In New Jersey 8/14/2025

    Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), held a ribbon-cutting ceremony yesterday to commemorate the grand opening of its new 60,000 sq. ft. GMP manufacturing facility and headquarters in Princeton, New Jersey.

35. AST Names Industry Veteran Jacob Stephen As Chief Operating Officer 8/13/2025

    AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company. Stephen joins AST from IPS, where he most recently served as Head of Operations for the Americas.

36. Pace® Life Sciences Debuts Enhanced cGMP Manufacturing Capabilities To Support Increasing Demand For Sterile Injectables 8/12/2025

    Pace^® Life Sciences, a U.S.-based CRDMO and full-service FDA-registered GMP Analytical Testing laboratory re-opened its 33,000 square foot facility in Salem, NH with advanced technologies to support small batch manufacturing.

37. Advancing Countermeasures Against Ebola And Deadly Viruses 8/12/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, has been selected by BARDA's Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to lead a project focused on "Manufacturing Optimization for Filovirus Human Monoclonal Antibodies."

38. Repligen Opens Training & Innovation Center To Elevate Customer Experience 8/7/2025

    Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its Repligen Training & Innovation Center (“RTIC”) at its Waltham headquarters.

39. Minaris Advanced Therapies Opens New Manufacturing Facility In Germany 8/6/2025

    Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new GMP manufacturing facility in Munich, Germany.  The facility, located in Taufkirchen, strengthens Minaris' global manufacturing network and reinforces its position as a trusted partner in advancing cutting-edge therapies from concept to commercialization.

40. Invetech And AiCella Announce Strategic Collaboration To Advance Cell Therapy Innovation 7/18/2025

    Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today announced a strategic collaboration with AiCella, a company focused on harnessing the power of artificial intelligence (AI) to optimize the development of cell therapy production processes and maximize patient response to treatment.